Loading...
Fibrobiologics Inc (FBLG) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks positive technical signals, has no significant trading trends, and its financial performance remains weak despite improvements in net income and EPS. Additionally, there are no recent news catalysts or influential trading activity to support a bullish outlook.
The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, the RSI is neutral at 37.628, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 0.268, with key support at 0.227 and resistance at 0.309.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Bearish technical indicators, lack of trading trends, and no recent news or influential trading activity.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income of -$5,778,000 (up 1055.60% YoY), and an EPS of -0.13 (up 1200% YoY). Despite improvements in net income and EPS, the financials remain weak with no revenue or gross margin.
No analyst rating or price target data available.